sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements." ;
    
dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    
dce:title "BEL Framework Large Corpus Document" ;
    
pav:authoredBy sub:_8 ;
    
pav:version "1.4" . 
  
sub:_7 prov:value "Treatment of A549 cells with TGF-beta1-induced IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation, IkappaBalpha phosphorylation, IkappaBalpha degradation, p65 Ser536 phosphorylation, and kappaB-luciferase activity. The TGF-beta1-mediated increases in IKKalpha/beta phosphorylation, p65 Ser536 phosphorylation, and kappaB-luciferase activity were inhibited by LY 294002, an Akt inhibitor" ;
    
prov:wasQuotedFrom pubmed:17307160 . 
  
sub:_8 rdfs:label "Selventa" . 
  
sub:assertion prov:hadPrimarySource pubmed:17307160 ;
    
prov:wasDerivedFrom beldoc: , 
sub:_7 . 
}